Assurance Infusion Recalls TRIMIX Injection Vials Due to Sterility Concerns
Assurance Infusion is recalling 1,290 vials of TRIMIX injection nationwide due to a lack of sterility assurance. No specific illnesses or injuries are reported in the source text.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance in an injectable drug, which poses a risk of harm (infection) even though no injuries are currently reported in the source text.
Plain-English summary
Assurance Infusion is voluntarily recalling 1,290 vials of TRIMIX 30MG/1MG/10MCG/ML INJ in 5 mL/10 mL vials. The recall is being conducted because of a lack of sterility assurance in the product.
The affected product was distributed nationwide within the United States. The source text lists numerous specific lot numbers and expiration dates ranging from December 2019 to April 2020.
The source text does not report any specific illnesses, injuries, or deaths associated with this recall. Consumers and healthcare providers should check their inventory for the listed lot numbers and contact the recalling firm for further instructions.
The recalled product
- Product
- TRIMIX 30MG/1MG/10MCG/ML INJ in 5 mL/10 mL vials Assurance Infusion (713) 533-8800
- Manufacturer
- Assurance Infusion
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1,290
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 07082019@29 Exp. 01/04/2020
- 06252019@11 Exp. 12/22/2019
- 07082019@29 Exp. 01/04/2020
- 06252019@6 Exp. 12/22/2019
- 07082019@28 Exp. 01/04/2020
- 07262019@3 Exp. 01/22/2020
- 07102019@13 Exp. 01/06/2020
- 07162019@13 Exp. 01/12/2020
- 07242019@15 Exp. 01/20/2020
- 07162019@12 Exp. 01/12/2020
- 08272019@11 Exp. 02/23/2020
- 08162019@6 Exp. 02/12/2020
- 07312019@14 Exp. 01/27/2020
- 07262019@4 Exp. 01/22/2020
- 08152019@9 Exp. 02/11/2020
- 08092019@6 Exp. 02/05/2020
- 07312019@15 Exp. 01/27/2020
- 08092019@5 Exp. 02/05/2020
- 08272019@12 Exp. 02/23/2020
- 09032019@36 Exp. 03/01/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 118 recalled by Assurance Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 118 products in this recall →Related recalls
Same manufacturer · Assurance Infusion
See all →- SevereAssurance Infusion Recalls Buprenorphine and Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Buprenorphine and Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15